ABSTRACT
INTRODUCTION
Abnormal uterine bleeding (AUB) is a significant problem in women of reproductive age 1 . Etiology is classified by the International Federation of Gynecology and Obstetrics as being either related or unrelated to uterine structural abnormalities and is categorized according to the acronym PALM-COEIN: polyp, adenomyosis, leiomyoma, malignancy and hyperplasia, coagulopathy, ovulatory disorder, endometrium, iatrogenic and not classified. AUB can be chronic or acute 2 . Considering the large number of women with AUB, polyps and leiomyomas being the most common pathology in these women, the negative impact on quality of life and the different options for clinical follow-up available, an effective method to evaluate the uterine cavity is necessary 3 . The diagnostic modalities used currently include conventional transvaginal ultrasound, two-(2D) and three-(3D) dimensional saline contrast sonohysterography (SCSH), hysteroscopy and uterine curettage [4] [5] [6] . SCSH has acquired an important role in the diagnosis of AUB, establishing itself as a complementary method to conventional transvaginal sonography in the evaluation of these cases 5 . It is used as an alternative to hysteroscopy in the diagnosis of uterine anomalies and postoperative assessment [5] [6] [7] [8] . It is less invasive and is well-tolerated, with reasonable costs and rare complications 5 . Another advantage of SCSH is its ability to evaluate submucosal leiomyomas. SCSH can evaluate size and depth and, with Doppler, vascularization of the leiomyoma, while hysteroscopy can visualize only a small part of the protruding fibroid in the endometrial cavity 4, 5 . Hysteroscopy remains the gold standard in the evaluation of the uterine cavity. However, the high costs and need for qualified professionals to carry out the procedure are factors that limit its use 4 . It is an invasive test that requires professional training and equipment in specialized centers.
Thus, there is a need to find a method with good sensitivity and specificity that is safe, affordable and effective. 2D-and 3D-SCSH appears to be a good, less invasive, less costly and more accessible alternative to hysteroscopy, being safe, with a low frequency of side effects, such as discomfort and minor pain, and with high sensitivity and specificity 5 . However, data on its effectiveness have not so far been consolidated for clinical practice. This systematic review aimed to evaluate the accuracy of 2D-and 3D-SCSH in diagnosing endometrial polyps and submucosal leiomyomas in women of reproductive age with AUB.
METHODS
A systematic review including only studies with an observational design that compared 2D-and/or 3D-SCSH with hysteroscopy and anatomopathology in the evaluation of uterine cavity abnormalities was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 9 and Synthesizing Evidence from Diagnostic Accuracy TEsts (SEDATE) 10 guidelines. To identify relevant studies, the electronic databases MEDLINE, EMBASE and The Cochrane Library were consulted, with searches conducted between December 2015 and March 2016, with no restriction on publication year or language. The retrieval of articles was conducted through search strategies described in Appendix S1, and were grouped and structured according to the Patient, Intervention, Control and Outcome (PICO) strategy. Publications listed in the references of selected articles were cross-checked. The studies selected were those that included patients of reproductive age with AUB who underwent 2D-or 3D-SCSH and hysteroscopy with anatomopathology. Retrospective baseline studies or those for which we did not have access to the full text were excluded. The selection of manuscripts obtained from the searches and evaluation of titles and abstracts were conducted by two researchers (C.A.B. and R.D.S.S.) in an independent and blinded manner, strictly observing the inclusion and exclusion criteria. The original study was evaluated for eligibility of inclusion in the review. Studies considered for inclusion in the meta-analysis were those presenting absolute values, allowing calculation of sensitivity and specificity. When there was disagreement among researchers on the selection of studies, a third reviewer was consulted (J.M.S.J.).
The methodology of the included studies was analyzed using qualitative instrument for data collection (Quality Assessment of Diagnostic Accuracy Studies-2; QUADAS-2), as recommended by the Healthcare Research and Quality Agency. This tool consists of four domains: patient selection, index test, reference standard, and flow and timing. All domains are assessed for risk of bias and the first three domains are assessed for applicability by indicating a low, high or unclear risk.
Information obtained from the selected studies was included in a summary table with author names, year of publication, country, patient parity, study design, number of patients, age, phase of menstrual cycle when tests were performed, test index (2D-or 3D-SCSH) and the reference test (hysteroscopy with anatomopathology). The statistical parameters true positive (TP), true negative (TN), false positive (FP) and false negative (FN) were extracted directly from the study and/or calculated and arranged in a 2 × 2 table. The sensitivity and specificity parameters, when unavailable directly, were calculated according to the following formulae: sensitivity = TP/(TP + FN) and specificity = TN/(FP + TN).
Meta-DiSk version 1.4 (http://www.hrc.es/investigacion /metadisc_en.htm) was used to perform the metaanalysis, which summarizes the diagnostic accuracy by means of a hierarchical summary receiver-operating characteristics (SROC) curve 11 . Presentation of metaanalysis data was by forest plots and SROC curves. Heterogeneity was explored by visual analysis of the SROC curve.
The primary outcomes of interest were the sensitivity, specificity and positive (LR+) and negative (LR-) likelihood ratios of SCSH in the detection of uterine cavity abnormalities (endometrial polyp or submucosal uterine leiomyoma) in women with AUB, compared with those for hysteroscopy and anatomopathology.
RESULTS

Eligible studies
The research process for identification and selection of studies is presented in Figure 1 . A total of 1398 articles were retrieved, of which five studies analyzing 2D-SCSH were selected for inclusion in the final
The Cochrane Library (n = 5)
Study not providing PICO components (n = 1334)
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References of selected studies cross-checked
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Figure 1
Flowchart of study selection and inclusion in systematic review. 2D, two-dimensional; 3D, three-dimensional; AUB, abnormal uterine bleeding; PICO, Patient, Intervention, Control and Outcome; SCSH, saline contrast sonohysterography.
analysis and meta-analysis. The principal reasons for exclusion were studies not providing components of PICO and heterogeneous population, inclusion of patients of postmenopausal age or studies analyzing together women of reproductive age and postmenopausal women (Table  S1 ). Other studies were not included in the review due to unavailability of absolute values that would enable calculation of sensitivity, specificity, LR+ and LR- 12, 13 . No study exploring the diagnostic accuracy of 3D-SCSH was included due to menopausal status, type of technique used and primary outcome of the study (investigation of infertility) (Table S2) .
Study characteristics
Clinical characteristics of included studies are detailed in Table 1 . The five studies included in the review were effectively cross-sectional without sample size calculation, each conducted at a single institution, including a total of 543 women [14] [15] [16] [17] [18] . Average patient age was 40 years, with the mean age among studies ranging from 30.6 to 44 years. All studies compared results of 2D-SCSH with those of hysteroscopy and anatomopathology.
Quality assessment
The methodological assessment of included studies according to QUADAS-2 is presented in Table 2 . Quality assessment showed one study with a low risk of bias for all four items 18 , two studies with a high risk of bias for two of the items (description of index test and reference standard) 14, 15 , while four studies had an unclear risk of bias for the description of flow and timing [14] [15] [16] [17] . Three studies had low risk for the three items of applicability [16] [17] [18] .
Data synthesis
The numbers of TP, TN, FP and FN were retrieved from each study and sensitivity, specificity, LR+ and LRwere calculated. For detection of endometrial polyps, sensitivity and specificity of 2D-SCSH ranged from 88% to 98% and from 61% to 100% among the five studies, respectively (Figure 2 ). Pooled analysis gave sensitivity and specificity of 93% (95% CI, 89-96%) and 81% (95% CI, 76-86%), respectively [14] [15] [16] [17] [18] . Pooled LR+ was 5.41 (95% CI, 2.60-11.28) and LR-was 0.10 (95% CI, 0.06-0.17). Only first author given for each study. All studies had cross-sectional study design. Parity and age are given as mean ± SD or median (range). NA, not available. 15 -
Only first author given for each study. +, high risk; -, low risk; ?, unclear risk.
For detection of submucosal uterine leiomyomas, 2D-SCSH had sensitivity and specificity ranging from 88% to 100% and from 61% to 100%, respectively, in the four studies reporting this diagnosis (Figure 3 ). Pooled analysis gave sensitivity and specificity of 94% (95% CI, 89-97%) and 81% (95% CI, 76-86%), respectively 14, 15, 17, 18 . Pooled LR+ was 4.25 (95% CI, 2.20-8.21) and LR-was 0.11 (95% CI, 0.05-0.22). Figure 4 presents SROC curves of 2D-SCSH in detecting endometrial polyps and submucosal uterine leiomyomas, showing areas under the curves of 0.968 ± 0.018 and 0.967 ± 0.027, respectively.
DISCUSSION
In this meta-analysis, 2D-SCSH had high sensitivity for the detection of endometrial polyps and submucosal uterine leiomyomas in women of reproductive age with AUB. This is one of the few systematic reviews and meta-analyses examining the diagnostic accuracy of SCSH in women of reproductive age with AUB. In the literature, there are a considerable number of studies examining the accuracy of this test in patients with AUB, but the analyzed populations are heterogeneous, including postmenopausal women or women with infertility 19, 20 . The study that most closely resembles the present analysis was a systematic review by Farquhar et al. in 2003 21 , in which the primary objective was to determine the diagnostic accuracy of transvaginal ultrasound, SCSH and hysteroscopy in the investigation of AUB. In their review, the inclusion criteria led to retrieval of studies with at least 60% of the women being of reproductive age and at least 50% of the women having menstrual disorders. Such eligibility criteria, as presented by the authors, constituted a source of considerable variability in the results 21 . Of the five studies included in our systematic review, all provided information that allowed calculation of the accuracy of 2D-SCSH for diagnosing endometrial polyps, but only four studies provided data related to submucosal uterine leiomyomas. The meta-analysis showed good accuracy of SCSH in detecting endometrial polyps and submucosal uterine leiomyomas, with a higher sensitivity for the diagnosis of the latter. These results demonstrate that, in women with AUB, 2D-SCSH can be considered as an alternative diagnostic modality to hysteroscopy, especially in detecting submucosal uterine leiomyomas. With regard to the diagnosis of endometrial polyps, our meta-analysis demonstrated high sensitivity. The areas under the SROC curves for the detection of endometrial polyps and submucosal uterine leiomyomas indicate that 2D-SCSH had values close to that of the gold standard. A good diagnostic test should have high LR+ (>5.0) and low LR-(< 0.2). In this meta-analysis, the LR+ value of 5.41 demonstrated that women with endometrial polyps had approximately a 5.4-fold greater chance of testing positive. However, for the detection of submucosal leiomyomas, LR+ was lower (4.25). This could be related to different phases in the menstrual cycle at which the tests were performed. LRof 0.1 revealed that a patient with an endometrial polyp or submucosal leiomyoma had a 10% chance of testing negative, demonstrating that this method is sensitive enough to rule out uterine cavity abnormalities in the case of a negative test result. However, because positive and negative predictive values depend on the prevalence of the disease in the population, the interpretation becomes difficult.
A strength of this study is the comprehensive review of the literature. This systematic review was conducted Cepni (2005) 14 (a) Sensitivity (95% CI) Jansen (2006) 15 Kamel (2000) 16 de Vries (2000) 17 Soguktas (2012) by two researchers in an independent and blinded manner, with strict selection of studies, particularly with regards to population selection, including only patients of reproductive age with AUB. This fact was decisive for exclusion of 3D-SCSH studies (Table S2 ). In addition, studies for which calculation of sensitivity and specificity values was not possible were excluded. Furthermore, studies included in the meta-analysis were evaluated rigorously for their methodology using the QUADAS-2 tool. We acknowledge that our review has some limitations. (1) Studies evaluating mixed populations of women Cepni (2005) 14 (a) Sensitivity (95% CI) 17 Soguktas (2012) of reproductive age and menopausal women were not considered. (2) The variability of the mean age of patients among studies should be considered for the possibility of these women being affected by different diseases. (3) Women were in different phases of the menstrual cycle when the tests were performed, which could have led to overdiagnosis of focal endometrial pathology 22 , and this information was even lacking in some studies. (4) There was a high risk of bias, mainly related to the index test and reference standard, in two of the studies 14, 15 , which did not contain information about the blinding status of the investigators. In addition, there was an unclear risk of bias due to the absence of information in most studies concerning the time between completion of the index test and the reference standard. If there is a delay or if treatment is started between the index test and reference standard, misclassification may occur due to recovery or deterioration of the condition. Other limitations of this review derive from the scarcity of data, small number of included studies and failure to retrieve the full text of four potentially eligible studies.
This review achieved its primary objectives, showing that 2D-SCSH is a highly sensitive technique, which is specific in detecting uterine cavity abnormalities, especially submucosal uterine leiomyomas and endometrial polyps in women of reproductive age with AUB, when compared with hysteroscopy. Other factors, such as lower cost, less discomfort and wide availability, make SCSH a potential first-line diagnostic tool in the work-up of women with AUB 23 . To provide an overview on cost comparison between SCSH and hysteroscopy, cost-effectiveness of diagnostic strategies for the management of AUB provided by the National Institute for Health Research estimated that cost of hysteroscopy was £3182, whereas the overall cost of SCSH was assumed to be £1083 24 . In conclusion, 2D-SCSH has high diagnostic accuracy for the detection of endometrial polyps and submucosal uterine leiomyomas in women of reproductive age with AUB. More studies are needed on 3D-SCSH in this population of women.
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Appendix S1 Electronic databases and their search strategies.
Table S1
Studies reporting on diagnostic accuracy of two-dimensional saline contrast sonohysterography excluded from systematic review and reason for exclusion 
